APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 13 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 41,825,000 | $77,769,000 | 1.38% |
| STEELHEAD PARTNERS LLC | 8,474,000 | $15,791,000 | 1.04% |
| DeepCurrents Investment Group LLC | 12,750,000 | $23,782,000 | 0.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 42,855,000 | $79,763,000 | 0.61% |
| SSI INVESTMENT MANAGEMENT LLC | 4,418,000 | $8,147,000 | 0.53% |
| LMR Partners LLP | 13,925,000 | $26,144,000 | 0.40% |
| MACKAY SHIELDS LLC | 19,851,000 | $36,702,000 | 0.34% |
| CSS LLC/IL | 2,500,000 | $4,653,000 | 0.19% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 10,500,000 | $19,571,000,000 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,306,000 | $6,173,000 | 0.14% |